Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
SINGLE-USE MARKET - Rise of Single-Use Technologies & Systems in Biopharmaceuticals November 19, 2015
Kevin James and Shalini S. Dewan of BCC Research believe eliminating the risk of contamination is the greatest challenge faced by manufacturers of biopharmaceuticals, and currently, this requires high-level monitoring of critical manufacturing processes. Single-use technology aids biopharmaceutical manufacturers in overcoming this challenge by reducing or eliminating the need for sterilization between batches, thereby improving operational efficiency.
EXECUTIVE INTERVIEW - Unither Pharmaceuticals: Premeasured Dosage Forms to Improve Medication Adherence November 18, 2015
Eric Goupil, CEO Unither Pharmaceuticals, speaks frankly about medication adherence, Unither’s technology, and some of the challenges that they face today.
BioXcel Initiates Strategic Big Data Partnership With Pronutria October 23, 2015
BioXcel Corporation recently announced the initiation of a strategic big data collaboration with Pronutria Biosciences to identify diseases characterized by...Merck Millipore Adds Protein Pegylation to Portfolio of Services Through Collaboration October 8, 2015
Merck Millipore recently announced a collaboration with celares GmbH to provide pegylation services to customers developing protein-based therapeutics and biosimilars....Hemispherx Biopharma Receives New Composition of Matter Patent October 5, 2015
Hemispherx Biopharma, Inc. recently announced it received formal notice on September 21, 2015, that the European Patent Office's Examining Division...Xcelience & Powdersize Add Delta Vita Nano-Milling September 28, 2015
Xcelience and Powdersize recently announced the addition of the Netzsch Delta Vitamedia mills, a nanoparticle milling solution, to their arsenal...Lubrizol CDMO Acquisition Significantly Broadens its Capabilities September 12, 2015
The Lubrizol Corporation recently announced it has acquired Particle Sciences, a leading contract drug development and manufacturing organization with a...Downstream Processing - BioProcess International Conference Pre-Event Podcast Series September 10, 2015
Hear talk previews from Recovery & Purification + Analytcal, Quality, and Formulations speakers Characterization of Host-Cell Proteins Using Mass...NanoViricides Reports Dramatic Effects of Topical Anti-Herpes Treatment Were Reproduced Once Again August 18, 2015
NanoViricides, Inc. recently reported that the dramatic improvements in clinical symptoms associated with herpes simplex virus infection were reproduced in...INDUSTRY PERSPECTIVES - The Future of the Pharma & Biotech Industries: Your Colleague’s Perspectives June 30, 2015
The Global Formulation Report in this issue provided some interesting data on what has been happening in a number of key sectors over the past 18 months. We thought it would be intriguing to hear what some of your colleagues believe will have a significant impact on the Pharma and Biotech industries throughout the next 5 to 10 years.
TASTE-MASKING - Pharmaceutical Taste-Masking Technologies June 30, 2015
Suniket Fulzele, PhD, and Sarah Rieschl present an overview and current status of the industrial approaches and platforms used for taste-masking in oral dosage forms.
Halozyme Enters Lucrative Global Collaboration & Licensing Agreement June 9, 2015
Halozyme Therapeutics, Inc. recently announced a global collaboration and license agreement with AbbVie to develop and commercialize products combining proprietary...SPECIAL FEATURE - Excipients: Enhancing the New, Poorly Soluble APIs June 1, 2015
Contributor Cindy H. Dubin interviews several excipient manufacturers who share their insights about the role excipients play in formulating and manufacturing drugs for improved bioavailability, solubility, and delivery.
SPECIAL FEATURE - Prefilled Syringes & Parenteral Contract Manufacturing: Anticipating the Needs of the Future May 5, 2015
Contributor Cindy H. Dubin speaks with several companies in the prefilled syringe and parenteral manufacturing market that are offering a range of services and systems that cater to today’s issues as well as anticipating the needs of the future.
ADVANCED DELIVERY DEVICES - Design & Evaluation of a Polymer-Based Prefillable Syringe for Biopharmaceuticals With Improved Functionality & Performance May 4, 2015
Sagarika Bose, PhD, and Kevin Constable address the design of a new commercially available polymer-based prefillable syringe with enhanced performance features when combined with complex biopharmaceutical drug products.
Aptar Pharma Twister® Chosen for Asthma Therapy April 2, 2015
Louveciennes, France - Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for...LIPID-BASED DELIVERY SYSTEMS - New Approaches for Macromolecule Oral Delivery, Abuse Deterrence & Bioavailability Enhancement March 31, 2015
Julien Meissonnier reviews the development of a broad range of advanced oral drug delivery technologies, including a toolkit of technologies based upon the broad application of lipid-based drug delivery systems for optimum solubility enhancement.
PhaseBio Raises $40 Million, Led By AstraZeneca March 17, 2015
PhaseBio Pharmaceuticals, Inc., a leading company in the field of biopolymer-based drugs and focused on developing treatments for metabolic and...SPECIAL FEATURE - Bioavailability & Solubility: A Demand for Enhanced Technologies & Materials is Spurring Innovation March 3, 2015
Contributor Cindy H. Dubin spoke with several contract research/manufacturing organizations on how they are successfully overcoming solubility/bioavailability challenges, such as matching APIs to formulations and choosing the best excipients.
MARKET BRIEF - Miniaturizing Healthcare - From Microelectronics to Nanobiosensing March 3, 2015
Cecilia Van Cauwenberghe, MS, Technical Insights Senior Research Analyst, Frost & Sullivan, reports that the proliferation of lower cost microfluidics-based genomics tools offering improved capabilities and allowing more access to end-users is expected to drive this technology for pharmaceutical and biomedical research throughout the next 5 years.














